In Q2 fiscal 2026 (the quarter ended June 30, 2026), Bristol-Myers Squibb's largest product or service was Net Product Sales, with $12.59 billion or 97% of revenue, up 5.7% from a year earlier. Next: Other Revenues (2%) and Alliance Revenues (1%).
By region, United States brought in 69%, Non-US brought in 28% and Other Region brought in 2% of revenue in Q2 fiscal 2026.
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Net Product Sales | $12.6B | $11.2B | $11.9B | $11.9B | 97% |
| Other Revenues | $281.0M | $227.0M | $247.0M | $241.0M | 2% |
| Alliance Revenues | $104.0M | $94.0M | $125.0M | $119.0M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $9.0B | $7.8B | $8.3B | $8.5B | 69% |
| Non-US | $3.7B | $3.4B | $3.6B | $3.5B | 28% |
| Other Region | $318.0M | $257.0M | $290.0M | $270.0M | 2% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Net Product Sales: $12.59 billion, or 97% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Net Product Sales (97%), Other Revenues (2%) and Alliance Revenues (1%).
By region in Q2 fiscal 2026: United States (69%), Non-US (28%) and Other Region (2%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item |
|---|